Related references
Note: Only part of the references are listed.Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis:: Impact of protein binding?
Brian S. Schwartz et al.
ANNALS OF PHARMACOTHERAPY (2008)
Mechanisms of resistance to daptomycin in Enterococcus faecium
Clemente I. Montero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
M. Sharma et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.
S. Roveta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis
Alicia I. Hidron et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
Russell Hope et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding
Tiffanny Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells
Carmela T. M. Mascio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Daptomycin versus vancomycin for complicated skin and skin structure infections: Clinical and economic outcomes
Susan L. Davis et al.
PHARMACOTHERAPY (2007)
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S-aureus (MRSA) blood isolates from 2001-05
Gregory Steinkraus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis:: an in vitro and in vivo simulation using historical and current dosing strategies
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
Pamela A. Moise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Telavancin: a novel lipoglycopeptide for serious Gram-positive infections
Somvadee Laohavaleeson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model
Alexander A. Firsov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections
Patrick A. Stone et al.
JOURNAL OF VASCULAR SURGERY (2006)
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
Mark Benvenuto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)
H. S. Sader et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients
E Bishop et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections
U Seybold et al.
CLINICAL INFECTIOUS DISEASES (2006)
Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients
JA Segreti et al.
PHARMACOTHERAPY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis
MS Rouse et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Sampling the antibiotic resistome
VM D'Costa et al.
SCIENCE (2006)
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus
JB Patel et al.
CLINICAL INFECTIOUS DISEASES (2006)
Antimicrobial agents in orthopaedic surgery - Prophylaxis and treatment
Andrej Trampuz et al.
DRUGS (2006)
Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
JA Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Linezolid in the treatment of Gram-positive prosthetic joint infections
M Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber
EW Hall et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy
TSJ Elliott et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin
LJ Ball et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis
JM Entenza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Dominance of EMRSA-15 and-16 among MRSA causing nosocomial bacteraemia in the UK:: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS) -: J Antimicrob Chemother 2001;: 48:143-144
AP Johnson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Effect of medium composition on the MIC breakpoint for gentamicin
JM Andrews
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
RH Drew et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus:: Evidence of resistance to vancomycin
J Burnie et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
